Evaluation of the effect of herbal food product in patients with COVID 19

INTERVENTION: Intervention 1: Intervention group: Shad syrup. The dosage of the syrup is 5 cc with 10 cc of water every 4 hours for the first two days and 5 cc every 6 hours for the next two days, which is given to the patient by the ward nurse and its consumption is monitored. Intervention 2: Control group: placebo. The dose is equivalent to non‐drug syrup for the first two days every 4 hours 5 cc with 10 cc of water and the next two days every 6 hours 5 cc which is given to the patient by the ward nurse and its consumption is monitored. CONDITION: COVID‐19. ; COVID‐19, virus identified U07.1 PRIMARY OUTCOME: BUN. Timepoint: Daily. Method of measurement: Biochemical testing. Cr. Timepoint: Daily. Method of measurement: Biochemical testing. CRP. Timepoint: Daily. Method of measurement: Biochemical testing. Death. Timepoint: daily. Method of measurement: Patient record. ESR. Timepoint: Daily. Method of measurement: ESR Reader. Fever (temperature ). Timepoint: Daily. Method of measurement: Thermometer. LDH. Timepoint: Daily. Method of measurement: Biochemical testing. SGOT. Timepoint: Daily. Method of measurement: Biochemical testing. SGPT. Timepoint: Daily. Method of measurement: Biochemical testing. SPO2. Timepoint: Daily. Method of measurement: Pulse oximetry. INCLUSION CRITERIA: confirmed COVID‐19 infection with Lab tests not considering sign and symptoms suspected COVID‐19 infection based on national protocol include the patients who has respiratory signs and pulmonary unilateral or bilateral multilobar infiltration in CT scan or chest radiography suspected patient to pneumonia with uncommon rapid deterioration and fast worsening of clinical status and not responding to proper treatments age 30 to 65